The expanded collaboration will include a three-year research partnership to develop a systematic process for drug repurposing and studying new uses for existing drugs. The collaboration will also feature chronic disease management initiative, which will combine Teva’s therapeutic technologies with IBM Watson’s cognitive computing. Respiratory and central nervous system diseases will be their chronic disease management initiative’s first targets.
The initiative will integrate data from The Weather Company, an IBM Business, into the analysis that will run on the IBM Watson Health Cloud.
“IBM and Teva’s announcements today are notable for two reasons. First, IBMs work with Teva extends from the biopharmaceutical research bench to an individual’s medicine cabinet — underscoring the power of Watson cognitive computing across life sciences and healthcare. Second, this work includes the first integration of data from The Weather Company with the Watson Health Cloud, a milestone and demonstrable of how the definition of health data is evolving,” said Deborah DiSanzo, general manager for IBM Watson Health, in a statement.
More articles on health IT:
Uber delivers free flu shots in 15 cities
Google donates $5M to Australian ‘best in the world’ healthcare startups
American Red Cross, Teladoc partner for disaster relief telehealth platform
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
